Recruiting

STI Testing

Sponsor:

Tulane University

Code:

NCT06428643

Conditions

Chlamydia

Gonorrhea

Hiv

Syphilis

Eligibility Criteria

Sex: All

Age: 15 - 26

Healthy Volunteers: Accepted

Interventions

Chlamydia, gonorrhea, syphilis, and HIV screening

Study Details

Brief summary:

This study includes testing for four STIs (chlamydia, gonorrhea, syphilis, and HIV) at no cost. If positive, individual subjects will also be counseled and offered options for treatment for themselves and their sex partners that may include no cost expedited treatment and the option to be rescreened 3 months after treatment.

Conditions

Chlamydia

Gonorrhea

Hiv

Syphilis

Study ID

NCT06428643

Start date

Aug 14, 2025

Status verified date

Apr, 2026

Completion date

Sep 1, 2029

Anticipated

Primary completion date

Sep 1, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 15 - 26

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Identifies as African American or Black
  • 15-26 years of age
  • Lives or spends most of their time in Orleans Parish
  • Had vaginal sex at least once

Exclusion Criteria:

  • Unwilling or unable to provide informed consent
  • Unable to speak or understand English
  • Previously enrolled in the study
  • Known to be pregnant
  • Known HIV positive status

Study Design

Enrollment

2322 participants

Anticipated

Intervention Model

Single group

Primary purpose

Screening

Interventions and Outcome Measures

Arms

experimental: Chlamydia, gonorrhea, syphilis, and HIV screening

Community screening of individuals for chlamydia and gonorrhea is not normally done. We are testing to see if this intervention will impact the rates of chlamydia among women.

Interventions

Chlamydia, gonorrhea, syphilis, and HIV screening

Individuals aged 15-26 years old will be tested for chlamydia, gonorrhea, HIV, and syphilis at community based venues. Individuals who test positive for chlamydia and gonorrhea and their sexual partners will be offered expedited treatment at participating pharmacies. Individuals who test positive will be asked to be rescreened for Ct/GC at 3 months post treatment.

Primary outcome measure

  • Rate of chlamydia in women [ Time Frame: up to 60 months ]

Central Contacts and Locations

Central contacts

Patricia Kissinger, PhD

504-988-7320kissing@tulane.edu

Locations

Tulane University Celia Scott Weatherhead School of Public Health and Tropical Medicine

Recruiting

New Orleans, Louisiana, United States, 70112

Contacts

Patricia Kissinger, PhD

504-988-7320kissing@tulane.edu

Momi Sagoe, MPH

504-988-1049msagoe@tulane.edu

Principal Investigator:

Patricia Kissinger, PhD

More Information

Sponsor

Tulane University

Last update posted

May 5, 2026

Last verified

Apr, 2026

Keywords

  • Screening
  • Expedited Treatment

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Tulane University on 2026-05-05.